149 related articles for article (PubMed ID: 35830924)
1. Quantitative proteomic analysis of oxaliplatin induced peripheral neurotoxicity.
Yang L; Wang H; Lu W; Yang G; Lin Z; Chen R; Li H
J Proteomics; 2022 Aug; 266():104682. PubMed ID: 35830924
[TBL] [Abstract][Full Text] [Related]
2. Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neurotoxicity.
Nepal MR; Taheri H; Li Y; Talebi Z; Uddin ME; Jin Y; DiGiacomo DF; Gibson AA; Lustberg MB; Hu S; Sparreboom A
Cancer Res Commun; 2022 Nov; 2(11):1334-1343. PubMed ID: 36506732
[TBL] [Abstract][Full Text] [Related]
3. Differential protein expression profiling by iTRAQ-2D-LC-MS/MS of rats treated with oxaliplatin.
Sun X; Lv Y; Wang J; Cheng H; Huang J; Du Y; Dong J
J Cell Biochem; 2019 Oct; 120(10):18128-18141. PubMed ID: 31237037
[TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment.
Kang L; Tian Y; Xu S; Chen H
J Neurol; 2021 Sep; 268(9):3269-3282. PubMed ID: 32474658
[TBL] [Abstract][Full Text] [Related]
5. L-tetrahydropalmatine reduces oxaliplatin accumulation in the dorsal root ganglion and mitochondria through selectively inhibiting the transporter-mediated uptake thereby attenuates peripheral neurotoxicity.
Yi Y; Li L; Song F; Li P; Chen M; Ni S; Zhang H; Zhou H; Zeng S; Jiang H
Toxicology; 2021 Jul; 459():152853. PubMed ID: 34252480
[TBL] [Abstract][Full Text] [Related]
6. Renin-Angiotensin-Aldosterone System Inhibitors Prevent the Onset of Oxaliplatin-Induced Peripheral Neuropathy: A Retrospective Multicenter Study and in Vitro Evaluation.
Uchida M; Ushio S; Niimura T; Takechi K; Kawazoe H; Hidaka N; Tanaka A; Araki H; Zamami Y; Ishizawa K; Kitamura Y; Sendou T; Kawasaki H; Namba H; Shibata K; Tanaka M; Takatori S
Biol Pharm Bull; 2022 Feb; 45(2):226-234. PubMed ID: 34803077
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of traditional plant-based medicines for preventing chronic oxaliplatin-induced peripheral neurotoxicity in patients with colorectal cancer: A systematic review and meta-analysis with core herb contribution.
Han J; Lai H; Li W; Liao H; Xiao C; Li X; You F; Guo J
J Ethnopharmacol; 2024 May; 326():117735. PubMed ID: 38211824
[TBL] [Abstract][Full Text] [Related]
8. Nrf2 inhibits oxaliplatin-induced peripheral neuropathy via protection of mitochondrial function.
Yang Y; Luo L; Cai X; Fang Y; Wang J; Chen G; Yang J; Zhou Q; Sun X; Cheng X; Yan H; Lu W; Hu C; Cao P
Free Radic Biol Med; 2018 May; 120():13-24. PubMed ID: 29530794
[TBL] [Abstract][Full Text] [Related]
9. Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity.
Alberti P; Canta A; Chiorazzi A; Fumagalli G; Meregalli C; Monza L; Pozzi E; Ballarini E; Rodriguez-Menendez V; Oggioni N; Sancini G; Marmiroli P; Cavaletti G
Neuropharmacology; 2020 Mar; 164():107905. PubMed ID: 31811874
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Huangqi Guizhi Wuwu Decoction for Oxaliplatin-Induced Peripheral Neurotoxicity: A Systematic Review and Meta-Analysis.
Yu J; Chen S; Wei G; Gu J; Huo J; Ding R; Li L
Altern Ther Health Med; 2024 Jan; 30(1):446-453. PubMed ID: 37820675
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic-toxicodynamic Modeling to Elucidate the Involvement of Dorsal Root Ganglion Neuron in Oxaliplatin-induced Peripheral Neuropathy.
Tsukushi Y; Kobuchi S; Ito Y; Sakaeda T
Anticancer Res; 2024 Feb; 44(2):575-584. PubMed ID: 38307592
[TBL] [Abstract][Full Text] [Related]
12. Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage?
Ballarini E; Malacrida A; Rodriguez-Menendez V; Pozzi E; Canta A; Chiorazzi A; Monza L; Semperboni S; Meregalli C; Carozzi VA; Hashemi M; Nicolini G; Scuteri A; Housley SN; Cavaletti G; Alberti P
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077454
[TBL] [Abstract][Full Text] [Related]
13. Mitotherapy prevents peripheral neuropathy induced by oxaliplatin in mice.
Maia JRLCB; Machado LKA; Fernandes GG; Vitorino LC; Antônio LS; Araújo SMB; Colodeti LC; Fontes-Dantas FL; Zeidler JD; Saraiva GN; Da Poian AT; Figueiredo CP; Passos GF; da Costa R
Neuropharmacology; 2024 Mar; 245():109828. PubMed ID: 38158014
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal Cancer.
Griffith KA; Zhu S; Johantgen M; Kessler MD; Renn C; Beutler AS; Kanwar R; Ambulos N; Cavaletti G; Bruna J; Briani C; Argyriou AA; Kalofonos HP; Yerges-Armstrong LM; Dorsey SG
J Pain Symptom Manage; 2017 Nov; 54(5):701-706.e1. PubMed ID: 28743660
[TBL] [Abstract][Full Text] [Related]
15. Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development.
Yang Y; Zhao B; Gao X; Sun J; Ye J; Li J; Cao P
J Exp Clin Cancer Res; 2021 Oct; 40(1):331. PubMed ID: 34686205
[TBL] [Abstract][Full Text] [Related]
16. Platinum accumulation in oxaliplatin-induced peripheral neuropathy.
Wei G; Gu Z; Gu J; Yu J; Huang X; Qin F; Li L; Ding R; Huo J
J Peripher Nerv Syst; 2021 Mar; 26(1):35-42. PubMed ID: 33462873
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: RILUZOX-01: protocol of a randomised, parallel, controlled, double-blind and multicentre study by the UNICANCER-AFSOS Supportive Care intergroup.
Kerckhove N; Busserolles J; Stanbury T; Pereira B; Plence V; Bonnetain F; Krakowski I; Eschalier A; Pezet D; Balayssac D
BMJ Open; 2019 Jun; 9(6):e027770. PubMed ID: 31182448
[TBL] [Abstract][Full Text] [Related]
18. Paeoniflorin ameliorates oxaliplatin-induced peripheral neuropathy via inhibiting neuroinflammation through influence on gut microbiota.
Xu J; Lu L; Jiang S; Qin Z; Huang J; Huang M; Jin J
Eur J Pharmacol; 2024 May; 971():176516. PubMed ID: 38513881
[TBL] [Abstract][Full Text] [Related]
19. The Class I HDAC Inhibitor, MS-275, Prevents Oxaliplatin-Induced Chronic Neuropathy and Potentiates Its Antiproliferative Activity in Mice.
Lamoine S; Cumenal M; Barriere DA; Pereira V; Fereyrolles M; Prival L; Barbier J; Boudieu L; Brasset E; Bertin B; Renaud Y; Miot-Noirault E; Civiale MA; Balayssac D; Aissouni Y; Eschalier A; Busserolles J
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008525
[TBL] [Abstract][Full Text] [Related]
20. PEA-OXA Mitigates Oxaliplatin-Induced Painful Neuropathy through NF-κB/Nrf-2 Axis.
Campolo M; Lanza M; Paterniti I; Filippone A; Ardizzone A; Casili G; Scuderi SA; Puglisi C; Mare M; Memeo L; Cuzzocrea S; Esposito E
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
